Tosk Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tosk Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10898
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tosk Inc (Tosk) is a drug developing company that provides development of safety and efficacy conditions of drugs. The company discovers and develops new drugs for cancer and other conditions using non-mammalian animal species as models for human diseases. It provides optimizing marketed drug technologies that uses drosophila as a model to screen compounds for their potential to reduce or eliminate the adverse effects of existing drugs. Tosk offers improving of safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis, psoriasis, and others. The company has its presence in Mountain View and Sunnyvale. Tosk is headquartered in Mountain View, California, the US.

Tosk Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tosk Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tosk Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tosk Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Tosk Raises Additional USD0.75 Million in Venture Financing 10
Tosk Raises Additional USD0.7 Million in Venture Financing 11
Tosk Raises Funds through Venture Financing 12
Tosk Raises US$1.3 Million In Seed Financing 13
Tosk Inc – Key Competitors 14
Tosk Inc – Key Employees 15
Tosk Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Feb 05, 2018: Tosk has been awarded a $2 million grant from National Cancer Institute to continue the company’s TK-kRAS research program 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Tosk Inc, Pharmaceuticals & Healthcare, Key Facts 2
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tosk Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tosk Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Tosk Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tosk Raises Additional USD0.75 Million in Venture Financing 10
Tosk Raises Additional USD0.7 Million in Venture Financing 11
Tosk Raises Funds through Venture Financing 12
Tosk Raises US$1.3 Million In Seed Financing 13
Tosk Inc, Key Competitors 14
Tosk Inc, Key Employees 15
Tosk Inc, Other Locations 16

List of Figures
Tosk Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tosk Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tosk Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tosk Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Humana Inc.:企業のM&A・事業提携・投資動向
    Humana Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Humana Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Marina Biotech, Inc.:企業の戦略・SWOT・財務情報
    Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kurumoch International Airport:企業の戦略・SWOT・財務分析
    Kurumoch International Airport - Strategy, SWOT and Corporate Finance Report Summary Kurumoch International Airport - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • T. Rowe Price Group, Inc.:企業のM&A・事業提携・投資動向
    T. Rowe Price Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's T. Rowe Price Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Cabot Oil & Gas Corp (COG):石油・ガス:M&Aディール及び事業提携情報
    Summary Cabot Oil & Gas Corp (Cabot) is an independent oil and gas company, which develops, and explores for oil and gas properties primarily in the continental US. It focuses on developing natural gas resources in the Marcellus shale in northeast Pennsylvania and oil development in the Eagle Ford s …
  • CMA CGM SA:企業のM&A・事業提携・投資動向
    CMA CGM SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CMA CGM SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Panasonic Corp (6752):企業の財務・戦略的SWOT分析
    Panasonic Corp (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Peyto Exploration & Development Corp (PEY):企業の財務・戦略的SWOT分析
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • Uni-President China Holdings Ltd
    Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • NewYork-Presbyterian Hospital:企業の戦略的SWOT分析
    NewYork-Presbyterian Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Laerdal Medical AS:企業の戦略的SWOT分析
    Laerdal Medical AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Great Wall Motor Co Ltd:企業の戦略・SWOT・財務分析
    Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Orange Belgium (OBEL):企業の財務・戦略的SWOT分析
    Orange Belgium (OBEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cognition Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment …
  • Mizuho Financial Group Inc:企業のM&A・事業提携・投資動向
    Mizuho Financial Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mizuho Financial Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Adaptive Biotechnologies Corp:医療機器:M&Aディール及び事業提携情報
    Summary Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company’s product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories for conductin …
  • JRI Orthopaedics Ltd:企業の製品パイプライン分析2018
    Summary JRI Orthopaedics Ltd (JRI) a subsidiary of Orthopaedic Research UK (ORUK), is a manufacturer of orthopaedic implants and surgical instruments. The company develops products for joint replacement, repair and reconstruction. It offers products for shoulder and knee arthoplasty, besides customi …
  • Ageas NV:企業の戦略・SWOT・財務情報
    Ageas NV - Strategy, SWOT and Corporate Finance Report Summary Ageas NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Power Assets Holdings Limited
    Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Novotech (Australia) Pty Ltd (Novotech) is a contract research organization that offers clinical development services. The organization’s services include clinical trials, data management, biostatistics analysis, audits, regulatory affairs, medical writing, site management and commercializat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆